Urine Cellular DNA Point Mutation and Methylation for Identifying Upper Tract Urinary Carcinoma.

Simple Summary: It's difficult to detect upper tract urothelial carcinoma at early stage. Invasive testing may increase risk of cancer recurrences in the bladder after radical nephroureterectomy. Thus, in the present study, we incorporated two-gene mutation and methylation biomarkers to conduct the...

Descripción completa

Detalles Bibliográficos
Publicado en:Cancers Vol. 14; no. 14
Autores principales: Ouyang, Wei, Luo, Lufeng, Zhang, Junjie, Xu, Ran, Lu, Qiang, Xu, Zhenzhou, Liu, Jianye, Li, Pei, Zhang, Yaqun, Zhou, Chuanchi, Tang, Wei, Wang, Zhenting, Cao, Manman, Xu, Genming, Wang, Long
Formato: research tables/charts Journal Article
Publicado: MDPI Jul2022
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=158214136&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 158214136
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        20726694
        B74B
      jtl: Cancers
      issn: 20726694
      maglogo: N
    pubinfo:
      dt: Jul2022
      vid: 14
      iid: 14
      pid: 97109
      pub: MDPI
    artinfo:
      ui:
        158214136
        158214136
        158214136
        10.3390/cancers14143537
        158214136
      ppct: 13
      formats:
      tig:
        atl: Urine Cellular DNA Point Mutation and Methylation for Identifying Upper Tract Urinary Carcinoma.
      aug:
        au:
          Ouyang, Wei
          Luo, Lufeng
          Zhang, Junjie
          Xu, Ran
          Lu, Qiang
          Xu, Zhenzhou
          Liu, Jianye
          Li, Pei
          Zhang, Yaqun
          Zhou, Chuanchi
          Tang, Wei
          Wang, Zhenting
          Cao, Manman
          Xu, Genming
          Wang, Long
        affil: Department of Urology, The Third Xiangya Hospital, Central South University, Changsha 410008, China
      sug:
        subj:
          DNA Urine
          Mutation
          Carcinoma, Transitional Cell Diagnosis
          Methylation
          Ureteroscopy
          Urinalysis Methods
          Carcinoma, Transitional Cell Urine
          Human
          Prospective Studies
          Hospitals
          Hematuria Diagnosis
          Polymerase Chain Reaction
          Random Forest
          Algorithms
          Descriptive Statistics
          Confidence Intervals
          Sensitivity and Specificity
          Liquid Biopsy
      ab: Simple Summary: It's difficult to detect upper tract urothelial carcinoma at early stage. Invasive testing may increase risk of cancer recurrences in the bladder after radical nephroureterectomy. Thus, in the present study, we incorporated two-gene mutation and methylation biomarkers to conduct the diagnostic tool of upper tract urothelial carcinoma and performed external validation to investigate the utility and stability of the optimal panel. It showed a highly specific and robust performance. It may be used as a replaceable approach for early detection of upper tract urothelial carcinoma, resulting in less extensive examinations in patients at low risk. Background: To improve the selection of patients for ureteroscopy, avoid excessive testing and reduce costs, we aimed to develop and validate a diagnostic urine assay for upper tract urinary carcinoma (UTUC). Methods: In this cohort study we recruited 402 patients from six Hunan hospitals who underwent ureteroscopy for hematuria, including 95 patients with UTUC and 307 patients with non-UTUC findings. Midstream morning urine samples were collected before ureteroscopy and surgery. DNA was extracted and qPCR was used to analyze mutations in TERT and FGFR3 and the methylation of NRN1. In the training set, the random forest algorithm was used to build an optimal panel. Lastly, the Beijing cohort (n = 76) was used to validate the panel. Results: The panel combining the methylation with mutation markers led to an AUC of 0.958 (95% CI: 0.933–0.975) with a sensitivity of 91.58% and a specificity of 94.79%. The panel presented a favorable diagnostic value for UTUC vs. other malignant tumors (AUC = 0.920) and UTUC vs. benign disease (AUC = 0.975). Furthermore, combining the panel with age revealed satisfactory results, with 93.68% sensitivity, 94.44% specificity, AUC = 0.970 and NPV = 98.6%. In the external validation process, the model showed an AUC of 0.971, a sensitivity of 95.83% and a specificity of 92.31, respectively. Conclusions: A novel diagnostic model for analyzing hematuria patients for the risk of UTUC was developed, which could lead to a reduction in the need for invasive examinations. Combining NRN1 methylation and gene mutation (FGFR3 and TERT) with age resulted in a validated accurate prediction model.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N